A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
Condition(s):SchizophreniaLast Updated:June 10, 2011Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:June 10, 2011Completed
Condition(s):Pediatric Bipolar DisorderLast Updated:July 4, 2012Terminated
Condition(s):SchizophreniaLast Updated:May 18, 2011Completed
Condition(s):SchizophreniaLast Updated:December 5, 2012Completed
Condition(s):SchizophreniaLast Updated:February 18, 2015Completed
Condition(s):SchizophreniaLast Updated:October 28, 2010Unknown status
Condition(s):SchizophreniaLast Updated:April 27, 2010Completed
Condition(s):Schizophrenia; Bipolar DisorderLast Updated:May 18, 2011Completed
Condition(s):Schizoaffective DisorderLast Updated:January 5, 2015Completed
Condition(s):Schizophrenia; Schizophrenic Disorders; Psychotic Disorders; Dementia PraecoxLast Updated:February 10, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.